Senior management changes at Aastrom Biosciences
This article was originally published in Scrip
Aastrom Biosciences (US) has announced that its CEO, president, chief financial officer and director, George Dunbar, will move out of day-to-day management duties and is expected to assume the role of chairman after the company's annual meeting of shareholders, which is planned for December 14th. Timothy Mayleben, a member of the company's board of directors and chair of the audit committee, will remain as a director and will become the Aastrom's new CEO, president and CFO in December. Nelson Sims, who has served as chairman since October 2008, is expected to assume the role of lead director.